Investing.com - H.C. Wainwright has reiterated its Buy rating on Microbot Medical (NASDAQ:MBOT) with a price target of $12.00 following the company’s third-quarter 2025 financial results. This target ...
Insights, news and analysis of the crypto market straight to your inbox ...
Microbot Medical Inc. (MBOT) has been beaten down lately with too much selling pressure. While the stock has lost 28.2% over the past four weeks, there is light at the end of the tunnel as it is now ...
Fintel reports that on October 15, 2025, HC Wainwright & Co. reiterated coverage of Microbot Medical (NasdaqCM:MBOT) with a Buy recommendation. Analyst Price Forecast Suggests 325.00% Upside As of ...
HINGHAM, Mass. - Microbot Medical Inc. (NASDAQ:MBOT), a medical device company with a market capitalization of $159 million, has secured a partnership with a U.S.-based third-party logistics company ...
Microbot Medical Announces Final Closing of Exercise of Outstanding Preferred Investment Options of Up to $92.2 Million in Gross Proceeds $25.2 million in first closing, $1.2 million in second closing ...
Microbot Medical (Nasdaq:MBOT) announced today that it exercised certain investment options worth up to $92.2 million. The Hingham, Massachusetts-based surgical robot maker said last month that ...
We recently published 10 Stocks Losing Big Amid Market Boom. Microbot Medical Inc. (NASDAQ:MBOT) is one of the worst performers on Thursday. Microbot extended its losing streak to a fourth consecutive ...
Microbot Medical Inc. (NASDAQ:MBOT), a medical device company with a market capitalization of $190 million, reported Monday it issued a total of 2,967,953 shares of its common stock from August 11 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback